Summary Opioid receptor binding was evaluated in parahippocampal cortex (PHC) obtained from patients with intractable mesial temporal lobe epilepsy (MTLE) with and without subacute high frequency electrical stimulation (HFS) in this brain area. Mu, delta and nociceptin receptor binding was determined by autoradiography in PHC of five patients (ESAE group) with MTLE history of 14.8 AE 2.5 years and seizure frequency of 11 AE 2.9 per month, two of them (40%) with mesial sclerosis. This group demonstrated antiepileptic effects following subacute HFS (130 Hz, 450 ms, 200-400 mA), applied continuously during 16-20 days in PHC. Values were compared with those obtained from patients with severe MTLE (history of 21.7 AE 2.8 years and seizure frequency of 28.2 AE 14 per month) in whom electrical stimulation did not induce antiepileptic effects (ESWAE group, n = 4), patients with MTLE in whom no electrical stimulation was applied (MTLE group, n = 4) and autopsy material acquired from subjects without epilepsy (n = 4 obtained from three subjects). Enhanced 3H-DAMGO (MTLE, 755%; ESAE, 375%; ESWAE, 693%), 3H-DPDPE (MTLE, 242%; ESAE, 80%; ESWAE, 346%) and 3H-nociceptin (MTLE, 424%; ESAE, 217%; ESWAE, 451%) binding was detected in the PHC of all epileptic groups. However, tissue obtained from ESAE group demonstrated lower opioid receptor binding (3H-DAMGO, 44.5%, p < 0.05; 3H-DPDPE,
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Introduction
We previously reported that subacute high frequency electrical stimulation (HFS) of the parahippocampal cortex (PHC) significantly decreases the number of interictal spikes at focus and abolished clinical seizures in patients with intractable mesial temporal lobe epilepsy (MTLE). 1 Blockage of temporal lobe epilepsy by PHC stimulation seems to be due, at least in part, to an inhibitory process of the stimulated area according with the following effects observed in the patients receiving HFS: (a) an increased threshold and decreased duration of the PHC afterdischarge and depression of the PHC evoked response recovery cycles, comparing the same patients before versus after PHC stimulation; (b) a single photon emission computed tomography (SPECT) hypoperfusion of the hippocampal region comparing the epileptic and stimulated side versus the normal and non-stimulated side in the same patient. 1, 2 We described that subacute electrical stimulation of PHC is more effective in producing antiepileptic effects in patients with less severe epilepsy, an effect associated with higher GABA tissue content and a low rate of cell loss, but without changes in GABA A and benzodiazepine receptor binding in PHC. 3 Experimental evidences support the involvement of opioid peptides in ictal, postictal and interictal activity. [4] [5] [6] [7] [8] [9] [10] Positron Emission Tomography (PET) studies revealed that the epileptogenic hippocampus from patients with MTLE shows reduced mu and delta receptor binding whereas the lateral temporal cortex of these patients, an area proposed to play an important role in the seizure expression and propagation, demonstrates an increase and nonsignificant changes of mu and delta receptors, respectively. 11, 12 The major purpose of the present study was the characterization of mu, delta and nociceptin receptor binding in PHC of patients with MTLE who showed antiepileptic effects after receiving subacute HFS in this brain area. Clinical and electrophysiological results obtained from these patients displaying antiepileptic effects during the HFS were previously reported.
1,2 Opioid receptor binding characterization may improve the understanding of the pathophysiology of a number of antiepileptic conditions associated with electrical stimulation, and it may greatly enhance the safety and efficacy of this therapy.
Material and methods
Subject selection and brain samples PHC tissue was obtained from patients with intractable MTLE history who underwent extensive preoperative phased evaluation in order to define focal areas of maximal epileptogenesis. None of the patients involved in the present study demonstrated gross structural lesions, such as tumors or vascular malformations. Table 1 provides a summary of the relevant clinical data and side of the epileptic focus for each patient.
HFS was applied in patients who, on the basis of history and neurological examination, were felt to be potential candidates, i.e. patients suffering from intractable complex partial seizures in whom invasive and non-invasive diagnostic procedures allowed to localize unilateral MTLE. Further details about the criteria for patient selection, electrode implantation, clinical characteristics and temporal lobectomy were previously reported. 1, 2 This study was approved by the scientific committees of the institutions involved in the present research and informed consent was obtained from each patient.
Patients were divided into four groups as follows: implanted at the pial surface of the basotemporal cortex through a wide temporal craniotomy to determine by electrocorticography the precise site and extent of the focus, followed by HFS in PHC during 16-20 days. Antiepileptic drugs were discontinued 48-74 h prior to electrical stimulation initiation as a conventional procedure to activate and localize the epileptic focus. 13 HFS was delivered by a pulse generator (model DBS, Medtronic Neurological, Minneapolis, MN, USA) attached to AD-TECH externalized connectors. 1 Stimuli consisted of continuous stimulation with biphasic Lilly wave pulses 130 per second in frequency, 450 ms in duration and 200-400 mA in amplitude. Lilly wave pulses is a type of electrical wave form which can be applied chronically for several months without causing detectable injury and significant changes in threshold.
14 The reliability of stimulation was daily determined by measurements of voltage, impedance and current flow at the intracerebral contacts throughout externalized electrode systems. Stimulation was interrupted only 1 h/day while EEG recordings were taken. Patients from this group showed significant decrease of interictal spike frequency (no. of spikes in 10 s) and number of seizures per day during the electrical stimulation.
1,2 MRI confirmed mesial sclerosis in two (40%) of these patients. Although this group showed a favorable response to the HFS, at present this procedure is not an official therapeutic approach. Then, at the completion of the clinical EEG and stimulation studies, patients underwent a second surgery in order to remove electrodes and carry out an ''en block'' anterior lobectomy, ipsilateral to the epileptic focus and PHC stimulation ( (Table 1) . d) Controls (C): control (n = 4) samples were obtained from three male subjects (right and left PHC samples were obtained from one subject) ranged in age from 20 to 30 years who died by sudden and violent causes (vehicle accident) and without history of neurological disease. Control samples were dissected at the time of autopsy, with a post mortem interval (PMI) of 2-3 h after death, immediately stored at À70 8C and then manipulated as described below.
Tissue preparation and histopathology
During the surgical procedure, PHC biopsies were collected immediately upon resection, quickly frozen in pulverized dry ice and stored at À70 8C.
Frozen sections of 20 mm were cut in a cryostat, thaw-mounted on gelatin-coated slides, and stored at À70 8C. Serial and parallel slides were obtained for histological analysis as well as for autoradiography (see below). Sections for histopathology were cresyl violet-stained. The average cell density per unit volume was determined by counting them under a light microscope equipped with a digitalized image analysis system, and according with the procedure described previously.
15,16
Autoradiography for mu, delta and nociceptin receptor binding
The autoradiography experiments were carried out on adjacent sections thaw-mounted on gelatincoated slides according to the procedures described previously. [17] [18] [19] Experimental conditions for mu, delta and nociceptin autoradiography are summarized in Table 2 . The brain sections were initially washed. Then, they were incubated in a solution containing the specific 3 H-ligand. Binding obtained in the presence of a non-labeled ligand was considered to be nonspecific. Values of the specific binding reported in the present study were obtained from the difference between nonspecific and total binding. Finally, incubation was terminated with two consecutive washes (1 min each) in buffer and a distilled water rinse (2 s) at 4 8C. The sections were quickly dried under a gentle stream of cold air, and then they were arrayed in X-ray cassettes and apposed to tritium-sensitive film together with tritium standards (Amersham) at room temperature. Thereafter, they were developed using standard Kodak developer (D-11) and fast fixer at room temperature. Optical densities were determined using a video-computer enhancement program (JAVA Jandel Video Analysis Software). For each PHC, 10 optical density readings were taken from at least five sections over the entire region resected, and were averaged. The optical density readings of the standards were used to determine tissue radioactivity values for the accompanying tissue sections and to convert them to fmol/mg protein.
Analysis of results and statistics
Receptor binding and cell count were examined statistically by analysis of variance (ANOVA) and a post-hoc Tukey test to determine significant differences. Since receptor binding values do not further allow assumptions on the exact receptor binding changes in areas with decreased cell density, proportions between receptor binding and cell count ([fmol/mg protein]/cell count) were obtained for each 3 H-ligand and experimental group. Finally, Pearson correlation coefficients were calculated to establish a significant correlation between receptor binding and neuronal cell counts. A significant correlation indicates that binding changes could be influenced by the cell density, whereas absence of correlation supports that binding alterations depend on receptor characteristics.
Results

Cell density and opioid receptor binding in control PHC
The cell density in PHC obtained at autopsy from subjects with no evidence of neurological disease was 37,604 AE 1769 cells/mm 3 
Cell density and opioid receptor binding in epileptic PHC
Histopathology evaluation revealed decreased cell count values in the PHC of the different epileptic groups (MTLE, 70%, p < 0.05; ESAE, 48.8%, p < 0.05; ESWAE, 72%, p < 0.05), when compared with control samples. However, ESAE group demonstrated significantly higher values (58.5%, p < 0.05) in contrast with MTLE group (Fig. 1) .
Quantification of receptor binding by autoradiography experiments demonstrated augmented 648 L. Rocha et al. (Fig. 2) .
The analysis of proportions between receptor binding and cell count revealed high 3 H-DAMGO (MTLE, 755%; ESAE, 375%; ESWAE, 693%), 3 H-DPDPE (MTLE, 242%; ESAE, 80%; ESWAE, 346%) and 3 H-nociceptin (MTLE, 424%; ESAE, 217%; ESWAE, 451%) binding in PHC of all epileptic patients. Nevertheless, the tissue obtained from ESAE group demonstrated lower values ( 3 H-DAMGO, 44.5%, p < 0.05; 3 H-DPDPE, 47%, p < 0.05; 3 H-nociceptin, 39.3%, p < 0.5) when compared with MTLE group (Fig. 2) .
Non-significant correlations were found between the cell density values and the 3 H-DAMGO, 3 H-DPDPE and 3 H-nociceptin binding evaluated for the different epileptic groups (Table 3 ). 
Discussion
The PHC is a region which has been suggested to play an important role in the intractable MTLE. 20 Our experiments revealed a significant decrease in the neuronal count and high mu, delta and nociceptin receptor binding in the surviving neurons of PHC of patients with MTLE. The absence of correlation between the reduced cell count and the receptor binding indicates that the opioid receptor binding alterations depend on changes in the receptor affinity or number, rather than the cell density.
Frost et al. 11 and Mayberg et al. 12 described an increase and non-significant changes of mu and delta receptors, respectively, in temporal cortex of patients with MTLE. In contrast with these reports in which PET was used to evaluate opioid receptor binding in vivo, the present study highlights a significant enhancement in mu, delta and nociceptin opioid receptor binding taking into account the cell loss. This situation could contribute to the debate concerning the role of opioid receptors in epilepsy.
Certainly, mu and delta receptors are also expressed in glial cells 21, 22 and opioid peptides may enhance their constitutive expression, 23 leading to suggest that enhanced gliosis may account for the high opioid receptor binding detected in PHC of patients with MTLE. However, it is necessary to consider that neuronal loss and gliosis may variably be present in the epileptic cortex. 24 In addition, within the abnormal cortex the most remarkable features are the presence of apoptotic bodies and the filling up by dendritic and axonal process, but not by glial process, of empty spaced left by the neurons that had disappeared. 25 This situation suggests that the high opioid receptor binding detected in PHC of epileptic patients must result from neuronal opioid receptor changes.
A critical factor for the present study is the postmortem delay that may modify the physical conditions of the tissue considered accurate reflection of control situation. Previously, it was demonstrated that at room temperature mu and delta receptor binding was significantly reduced within 12 h but not at 6 h postmortem. 26 Concerning nociceptin receptors, 3 H-nociceptin ligand binding and nociceptin opioid receptor mRNA expression are well preserved in the human brain with a postmortem interval of 6-29.5 h. 27 For the present study, control values can be considered acceptable and valid for analysis because autopsy control samples were collected from 2 to 3 h after death and immediately stored at À70 8C.
Some characteristics of the epileptic patients could be associated with the antiepileptic effect induced by HFS. When compared with the nonresponding patients (ESWAE group), the responding patients (ESAE group) were younger, with a shorter seizure history, smaller seizure frequency, lower incidence of mesial temporal sclerosis, higher GABA tissue content and reduced cell loss in the PHC. 3 Further studies are necessary to elucidate if the smaller increases of opioid receptor binding in PHC represent an intrinsic characteristic of the patients susceptible to present anticonvulsant effects induced by HFS, or it is a consequence of the repetitive exposure to the endogenous opioids released by HFS. 28, 29 In addition, the lower susceptibility to the HFS-induced antiepileptic effects of patients with higher opioid receptor binding in PHC (ESWAE group) supports the notion that the activation of mu, delta and nociceptin opioid receptors facilitates the seizure activity. [8] [9] [10] [30] [31] [32] [33] [34] The enhanced activation or release of inhibitory neurotransmitters such as GABA has been proposed as a mechanism of HFS to induce inhibitory effects. 35, 36 On the other hand, the activation of mu, delta and nociceptin opioid receptors can inhibit GABA release resulting in the suppression of the GABA-mediated synaptic transmission. 31, 37, 38 It is possible that the GABA-mediated inhibitory effects induced by HFS are facilitated in the PHC of the responding patients that present a smaller increase of opioid receptors.
Our experiments revealed that patients responding to the HFS demonstrated less rate of cell damage in PHC. It is described that HFS mimics the effects of ablative procedures, considered as inhibitory. 39 In fact, chronic HFS produces an effect analogous to that seen after lesions. 40 It is interesting to note that cerebral insults associated with nervous tissue lesions result in decreased mu and delta opioid receptors. 41, 42 It is possible that the ''lesion'' effects induced by HFS reduce the increased mu and delta receptor binding in PHC of epileptic patients. Concerning nociceptin receptor binding, its activation enhances excitotoxic lesions, an effect augmented by the activation of mu receptors. 43 Experiments should be carried out to further investigate if the elevated opioid receptor binding is associated with the high cell loss detected in PHC of non-responding patients. Finally, the results obtained lead to suggest that the non-invasive characterization of the cerebral opioid receptors and potentially epileptogenic lesions including mesial temporal sclerosis, using techniques such as PET and MRI, may become clinically useful in the initial selection of candidate epileptic patients to receive electrical stimulation therapy.
